LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 61.56 | 27.76 | 3182 | 6217 | 0.5118 | 0.8356 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 61.56 | 27.76 | 5811 | 6217 | 0.9347 | 0.9828 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 61.56 | 27.76 | 945 | 6217 | 0.1520 | 0.5712 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 61.56 | 27.76 | 7641 | 6217 | 1.2290 | 1.0535 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 63.26 | 27.76 | 3301 | 6465 | 0.5105 | 0.8361 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 63.26 | 27.76 | 6059 | 6465 | 0.9371 | 0.9836 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 63.26 | 27.76 | 1571 | 6465 | 0.2430 | 0.6707 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 63.26 | 27.76 | 8006 | 6465 | 1.2382 | 1.0551 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 64.97 | 27.76 | 3362 | 6656 | 0.5051 | 0.8344 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 64.97 | 27.76 | 6263 | 6656 | 0.9408 | 0.9846 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 64.97 | 27.76 | 1491 | 6656 | 0.2240 | 0.6552 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 64.97 | 27.76 | 8443 | 6656 | 1.2683 | 1.0610 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 66.67 | 27.76 | 3084 | 6695 | 0.4606 | 0.8134 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 66.67 | 27.76 | 6488 | 6695 | 0.9690 | 0.9921 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 66.67 | 27.76 | 1790 | 6695 | 0.2673 | 0.6929 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 66.67 | 27.76 | 8759 | 6695 | 1.3082 | 1.0690 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 68.37 | 27.76 | 3010 | 6879 | 0.4376 | 0.8026 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 68.37 | 27.76 | 6620 | 6879 | 0.9623 | 0.9904 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 68.37 | 27.76 | 1777 | 6879 | 0.2583 | 0.6870 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 68.37 | 27.76 | 9092 | 6879 | 1.3217 | 1.0714 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 70.08 | 27.76 | 2516 | 6849 | 0.3673 | 0.7632 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 70.08 | 27.76 | 6779 | 6849 | 0.9897 | 0.9974 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 70.08 | 27.76 | 1790 | 6849 | 0.2613 | 0.6892 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 70.08 | 27.76 | 9307 | 6849 | 1.3587 | 1.0787 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 71.78 | 27.76 | 2319 | 6893 | 0.3364 | 0.7441 | MN20160318_Q01 | F04 |